drugset / Trial / NCT00907530
Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain
RandomizedCrossoverDouble-blindDiagnostic
Summary
This study is being conducted as a phase IV, double-blind, multi-center, randomized, crossover trial aimed at a within-subject comparison of MULTIHANCE and GADOVIST at a dose of 0.1 mmol/kg, in terms of qualitative and quantitative assessment of unenhanced MRI (UE MRI) and contrast-enhanced MRI (CE MRI) for the visualization of brain disease.
Timeline
- Start
- 2009-09
- Primary completion
- 2011-03
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gadobenate dimeglumine | Diagnostic / imaging agent | 0.1 unknown | — |
| Comparator | Gadobutrol | Diagnostic / imaging agent | 0.1 unknown | — |
Indications
No indication recorded.